Chronic Myelomonocytic Leukemia (CMML) Latest Advances
Find the Latest Research About Chronic Myelomonocytic Leukemia (CMML)
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2095 publications
Dysregulated neutrophil extracellular trap formation is a novel driver of clonogenicity and therapeutic vulnerability in CMML.
Journal: bioRxiv : the preprint server for biology
Published: August 19, 2026
Additional myelodysplasia-related gene mutations alter clinical presentation and worsen prognosis in patients with SRSF/TET2 co-mutated myeloid neoplasms.
Journal: Leukemia & lymphoma
Published: August 12, 2026
Sequential Neutrophilic Dermatoses Heralding Chronic Myelomonocytic Leukemia: An Overlapping Myelomonocytic Immunophenotype in Skin and Marrow.
Journal: International journal of dermatology
Published: July 17, 2026
Factors implicated in underutilization and poor persistence with hypomethylating agent therapy in myelodysplastic syndromes and chronic myelomonocytic leukaemia in Pakistan.
Journal: JPMA. The Journal of the Pakistan Medical Association
Published: July 14, 2026
CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of Nras G12D-driven chronic myelomonocytic leukemia.
Journal: Cancer biology & therapy
Published: June 22, 2026
Chronic Myelomonocytic Leukemia (CMML) with Novel t(1;3)(p36.2;p12): Dual-locus Genomic Disruption Associated with Early Mortality.
Journal: Journal of the Association of Genetic Technologists
Published: June 05, 2026
Integrated Transcriptomic Analysis and Molecular Modeling Identify ENO1 and Naftopidil as Candidates for Chronic Myelomonocytic Leukemia.
Journal: Current medicinal chemistry
Published: June 03, 2026
Last Updated: 09/26/2026